Bilezikian JP - Search Results

1

Methodology for the Guidelines on Evaluation and Management of Hypoparathyroidism and Primary Hyperparathyroidism.

Yao L, Guyatt G, Ye Z, Bilezikian JP, Brandi ML, Clarke BL, Mannstadt M, Khan AA. Yao L, et al. Among authors: bilezikian jp. J Bone Miner Res. 2022 Nov;37(11):2404-2410. doi: 10.1002/jbmr.4687. Epub 2022 Oct 17. J Bone Miner Res. 2022. PMID: 36053800 Free article.

2

Characterization and evaluation of asymptomatic primary hyperparathyroidism.

Bilezikian JP, Silverberg SJ, Shane E, Parisien M, Dempster DW. Bilezikian JP, et al. J Bone Miner Res. 1991 Oct;6 Suppl 2:S85-9; discussion S121-4. doi: 10.1002/jbmr.5650061419. J Bone Miner Res. 1991. PMID: 1662460 Free article.

3

Primary hyperparathyroidism: pathophysiology and impact on bone.

Khan A, Bilezikian J. Khan A, et al. CMAJ. 2000 Jul 25;163(2):184-7. CMAJ. 2000. PMID: 10934983 Free PMC article. Review.

4

Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century.

Bilezikian JP, Potts JT Jr, Fuleihan Gel-H, Kleerekoper M, Neer R, Peacock M, Rastad J, Silverberg SJ, Udelsman R, Wells SA Jr. Bilezikian JP, et al. J Bone Miner Res. 2002 Nov;17 Suppl 2:N2-11. J Bone Miner Res. 2002. PMID: 12412771 Review. No abstract available.

5

Asymptomatic primary hyperparathyroidism: new issues and new questions--bridging the past with the future.

Bilezikian JP, Potts JT Jr. Bilezikian JP, et al. J Bone Miner Res. 2002 Nov;17 Suppl 2:N57-67. J Bone Miner Res. 2002. PMID: 12412779 Review.

6

Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial.

Khan AA, Bilezikian JP, Kung AW, Ahmed MM, Dubois SJ, Ho AY, Schussheim D, Rubin MR, Shaikh AM, Silverberg SJ, Standish TI, Syed Z, Syed ZA. Khan AA, et al. Among authors: bilezikian jp. J Clin Endocrinol Metab. 2004 Jul;89(7):3319-25. doi: 10.1210/jc.2003-030908. J Clin Endocrinol Metab. 2004. PMID: 15240609 Clinical Trial.

7

Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features.

Bilezikian JP, Brandi ML, Rubin M, Silverberg SJ. Bilezikian JP, et al. J Intern Med. 2005 Jan;257(1):6-17. doi: 10.1111/j.1365-2796.2004.01422.x. J Intern Med. 2005. PMID: 15606372 Free article. Review.

8

Standards for performing DXA in individuals with secondary causes of osteoporosis.

Khan AA, Hanley DA, Bilezikian JP, Binkley N, Brown JP, Hodsman AB, Josse RG, Kendler DL, Lewiecki EM, Miller PD, Olszynski WP, Petak SM, Syed ZA, Theriault D, Watts NB; Canadian Panel of the International Society for Clinical Densitometry. Khan AA, et al. Among authors: bilezikian jp. J Clin Densitom. 2006 Jan-Mar;9(1):47-57. doi: 10.1016/j.jocd.2006.01.001. Epub 2006 Apr 4. J Clin Densitom. 2006. PMID: 16731431

9

Dynamic and structural properties of the skeleton in hypoparathyroidism.

Rubin MR, Dempster DW, Zhou H, Shane E, Nickolas T, Sliney J Jr, Silverberg SJ, Bilezikian JP. Rubin MR, et al. Among authors: bilezikian jp. J Bone Miner Res. 2008 Dec;23(12):2018-24. doi: 10.1359/jbmr.080803. J Bone Miner Res. 2008. PMID: 18684087 Free PMC article.

10

The diagnosis and management of asymptomatic primary hyperparathyroidism revisited.

Khan AA, Bilezikian JP, Potts JT Jr; Guest Editors for the Third International Workshop on Asymptomatic Primary Hyperparathyroidism. Khan AA, et al. Among authors: bilezikian jp. J Clin Endocrinol Metab. 2009 Feb;94(2):333-4. doi: 10.1210/jc.2008-1757. J Clin Endocrinol Metab. 2009. PMID: 19193907 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

634 results

Search Page